These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 801666)

  • 21. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
    Rautemaa R; Richardson M; Pfaller M; Koukila-Kähkölä P; Perheentupa J; Saxén H
    J Antimicrob Chemother; 2007 Oct; 60(4):889-92. PubMed ID: 17704513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Candida albicans meningoencephalomyeloradiculitis].
    Tiberghien F; De Seze J; Stojkovic T; Delmaire C; Gauvrit JY; Sendid B; Vermersch P
    Rev Neurol (Paris); 2002 Apr; 158(4):473-6. PubMed ID: 11984492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Streptococcus pyogenes: a rare etiology of non-gonococcal urethritis and balanitis in the adult].
    Nicolas X; Granier H; Le Guen P; Chapalain JC; Rouby Y; Talarmin F
    Med Mal Infect; 2006 Mar; 36(3):170-1. PubMed ID: 16309875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CARE-2 fingerprinting of Candida albicans isolates.
    Morschhäuser J; Staib P; Köhler G
    Methods Mol Med; 2005; 118():27-34. PubMed ID: 15888932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in epidemiology of opportunistic infections due to Candida].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of fresh garlic extract on Candida albicans biofilms.
    Shuford JA; Steckelberg JM; Patel R
    Antimicrob Agents Chemother; 2005 Jan; 49(1):473. PubMed ID: 15616341
    [No Abstract]   [Full Text] [Related]  

  • 27. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
    Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
    J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential risk factors for infection with Candida spp. in critically ill patients.
    Peres-Bota D; Rodriguez-Villalobos H; Dimopoulos G; Melot C; Vincent JL
    Clin Microbiol Infect; 2004 Jun; 10(6):550-5. PubMed ID: 15191384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of Candida albicans fungemia during voriconazole therapy.
    Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D
    J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209
    [No Abstract]   [Full Text] [Related]  

  • 31. [Analysis of various factors in Candida albicans infection (proceedings)].
    Fegeler W
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):342-5. PubMed ID: 790848
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection.
    Yordanov M; Dimitrova P; Patkar S; Saso L; Ivanovska N
    Can J Microbiol; 2008 Jun; 54(6):435-40. PubMed ID: 18535628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Candida albicans spondylitis: successful treatment with fluconazole. 2 case reports].
    Rösler-Meier D; Brunner-La Rocca HP; Senn P; Schlumpf U
    Praxis (Bern 1994); 1996 Apr; 85(16):520-5. PubMed ID: 8657996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to positive culture and identification for Candida blood stream infections.
    Fernandez J; Erstad BL; Petty W; Nix DE
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):402-7. PubMed ID: 19446982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retinal candidiasis].
    Francois MM; Turut P; Guilbert MF
    Arch Ophtalmol Rev Gen Ophtalmol; 1974 Dec; 34(12):863-77. PubMed ID: 4282462
    [No Abstract]   [Full Text] [Related]  

  • 38. [Resistance against Candida is a current problem].
    Osterlund A; Strand A
    Lakartidningen; 1998 Oct; 95(41):4476-7. PubMed ID: 9803739
    [No Abstract]   [Full Text] [Related]  

  • 39. Infectious balanoposthitis: management, clinical and laboratory features.
    Lisboa C; Ferreira A; Resende C; Rodrigues AG
    Int J Dermatol; 2009 Feb; 48(2):121-4. PubMed ID: 19200183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP; Fan SR; Bai FY; Li J; Liao QP
    Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.